AIM Trademark

Trademark Overview


On Friday, February 7, 2020, a trademark application was filed for AIM with the United States Patent and Trademark Office. The USPTO has given the AIM trademark a serial number of 88788692. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, January 17, 2024. This trademark is owned by AIM ImmunoTech Inc.. The AIM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
aim

General Information


Serial Number88788692
Word MarkAIM
Filing DateFriday, February 7, 2020
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, January 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAIM ImmunoTech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOcala, FL 34473

Trademark Events


Event DateEvent Description
Wednesday, January 17, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 15, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 30, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 20, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 27, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 27, 2020LETTER OF SUSPENSION E-MAILED
Friday, November 27, 2020SUSPENSION LETTER WRITTEN
Thursday, November 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 4, 2020NON-FINAL ACTION E-MAILED
Monday, May 4, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 28, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 11, 2020NEW APPLICATION ENTERED